BARDA’s Big Bird Flu Vax Contract With Moderna
Last month, Moderna, Inc. slashed its revenue forecast for this year by $1 billion, prompting its stock price to plunge by more than 20 percent to $33.44. In September 2024, Moderna estimated its revenue for 2025 would be $2.5 billion to $3.5 billion, but the company revised its forecast on Jan. 13, 2025 to $1.5 […]
Baby Dies an Hour After Getting Seven Vaccines—But You Can’t Question the Shots?
Imagine taking your perfectly healthy baby to the pediatrician for a “well-baby visit.” You allow the doctor to give your baby all the scheduled vaccines and, within an hour, your healthy baby is dead. Considering that your baby was administered 7-8 vaccines—one right after the other, you naturally assume the vaccines may have had something […]
Ex U.K. British WHO Director Spill the Beans About World Health Organization
The WHO was a great organization in the past, set up after the ravages of the second World War to help world global health. It’s sort of lost its way about 25 years ago. You could see, it’s an organization of bureaucrats. The director, for example, isn’t even a medically qualified doctor. And it’s just […]
FDA Lab Uncovers Excess DNA Contamination in COVID-19 Vaccines
An explosive new study conducted within the U.S. Food and Drug Administration’s (FDA) own laboratory has revealed excessively high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine. Tests conducted at the FDA’s White Oak Campus in Maryland found that residual DNA levels exceeded regulatory safety limits by 6 to 470 times. The study was undertaken […]
FDA Clears Investigational New Drug Application for Inhaled COVID Biologic
Biotech company Ocugen, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared their Investigational New Drug (IND) application for a novel inhaled vaccine against SARS-CoV-2. The biologic uses novel chimpanzee adenovirus-vectored (ChAd36) technology. The approval will allow the company to initiate Phase I clinical trials for the inhaled vaccine, OCU500. The […]
Pfizer’s Corporate Partnership With American Cancer Society Raises Conflict of Interest Questions
Pfizer, Inc. reported that it has been named the American Cancer Society’s (ACS) “2024 Corporate Partner of the Year.” The award acknowledges Pfizer’s ongoing development of products that treat cancer. However, legitimate conflict of interest issues arise when non-profit disease charities become involved in corporate partnerships with pharmaceutical companies that promote therapies and market products […]